AAD's Dialogues in Dermatology

221 Episodo

1. Practice Management Series: Physician Burnout and Wellness

   Publicado: 2/4/2024
2. Bonus: AAD 2024 Election: President-Elect (Dr. Murad Alam) and Vice President-Elect (Dr. Larry Green)

   Publicado: 26/3/2024
3. February JAAD: Bridging the Specialty Gap: Update on Primary Cutaneous Lymphomas

   Publicado: 20/3/2024
4. March JAAD: Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: a multivariable model and web-based calculator

   Publicado: 20/3/2024
5. Guidelines of Care: Awareness of Comorbidities Associated with Atopic Dermatitis in Adults

   Publicado: 22/2/2024
6. Bonus: Vitiligo

   Publicado: 16/2/2024
7. Bonus: AAD 2024 Election: President-Elect Candidate Interview (Dr. Robert T. Brodell)

   Publicado: 15/2/2024
8. Bonus: AAD 2024 Election: President-Elect Candidate Interview (Dr. Murad Alam)

   Publicado: 15/2/2024
9. January JAAD: Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations/Part II: disease activity grading and therapeutic management

   Publicado: 7/2/2024
10. Practice Management Series: Preventing and Surviving Payer Audits

    Publicado: 1/2/2024
11. Practice Management Series: Coding Updates for 2024

    Publicado: 18/1/2024
12. December JAAD: A reappraisal of the epidemiology of Spitz neoplasms in the molecular era: A retrospective cohort study

    Publicado: 3/1/2024
13. November JAAD: Gaps in Medical Education Curricula on Skin of Color in Medical School, Residency, and Beyond

    Publicado: 3/1/2024
14. Practice Management Series: Appropriate Use of Multiple Procedure Modifiers

    Publicado: 20/11/2023
15. Bonus: Novel Pathways in Psoriasis - An Immunological and Pathogenic Perspective (Sponsored by Bristol Myers Squibb)

    Publicado: 16/10/2023
16. October JAAD: Adalimumab in conjunction with surgery compared with adalimumab monotherapy for Hidradenitis Suppurativa: A randomized controlled trial in a real-world setting

    Publicado: 10/10/2023
17. September JAAD: Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: results from an open-label extension of the phas

    Publicado: 20/9/2023
18. Guidelines Series: Guidelines of Care for the Management of Actinic Keratoses

    Publicado: 12/9/2023
19. Practice Management Series: Effective Appeals to Payer Denials

    Publicado: 25/8/2023
20. August JAAD: Emerging Treatments for Itch in Atopic Dermatitis: A Review

    Publicado: 11/8/2023